Buscar resultados de ensayos clínicos
Intraocular Lymphoma - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Lenalidomide Plus Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma Condición:
Fecha: 2012-02-27 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma Condición:
Intervenciones: Drug: Ibrutinib p.o. 560 mg once a day (four 140 mg capsules) for one year (12 cycles of 28 days) |
Completed |
Nombre del estudio: A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain Lymphoma Condición:
Fecha: 2005-09-14 Intervenciones: Drug: Intraventricular Rituximab Plus MTX Intraventricular |
Suspended |
Nombre del estudio: Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma or Newly Diagnosed or Relapsed or Refractory Intraocular Lymphoma Condición:
Intervenciones: |
Withdrawn |
Nombre del estudio: Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma Condición:
|
Completed |
Nombre del estudio: Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma Condición:
|
Active, not recruiting |
Nombre del estudio: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma Condición:
Intervenciones: |
Completed |
Nombre del estudio: Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma Condición:
|
Completed |
Nombre del estudio: 3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma Condición:
|
Completed |
Nombre del estudio: 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas Condición:
|